Welcome to ACC's Vascular Disease Member Section!

Osama A. Ibrahim, MD, FACC

Osama A. Ibrahim, MD, FACC
Chair

On behalf of the entire Vascular Disease Leadership Council, welcome to ACC's Vascular Disease Member Section!

In recent years, the vascular field has significantly expanded with improvements in prevention strategies, early screening methods, imaging technologies, pharmacological therapies and procedural innovations. These developments include carotid artery revascularization, lower extremity limb salvage and amputation prevention practices, catheter-based therapies for venous thromboembolism and renal artery denervation for refractory/resistant hypertension.

The scope of vascular disease encompasses many aspects of cardiovascular medicine, including prevention, imaging, cardiometabolic risk modification, flow restoration therapies in both the arterial and venous space, and lifelong surveillance strategies for these patients.

These advancements have increased the need for greater awareness among our ACC Membership through education, collaboration with various ACC councils, cooperation with other vascular societies, advocacy efforts to address the growing lower extremity amputation crisis, and delivering science-based, quality-driven outcomes in this emerging field. We look forward to continued progress and engagement with the broader ACC membership, including all providers, CV team members and patient advocates.

Osama A. Ibrahim, MD, FACC
Chair, Vascular Disease Member Section

Join the Vascular Disease Member Section — Today!

The Vascular Disease Member Section is only able to accomplish its mission through support from members. Members can join online by clicking here or by contacting ACC Member Care at (800) 253-4636, ext. 5603; or direct dial (202) 375-6000.

Already a member of the Vascular Disease Section? Click here to unlock the member exclusive section experience.

As our membership grows, so does the Vascular Disease Member Section's opportunities to impact College policies and provide additional member benefits.

Questions?

Questions? Contact ACC Member Care.

Section Announcements

Section News

ACC26

Pick Between Pathways at ACC.26

December 2, 2025

Upcoming Event

Join practice-changing, interactive sessions spanning the full spectrum of vascular medicine with the Vascular Diseases Learning Pathway and the Pulmonary Vascular Disease (PVD) Learning Pathway at ACC.26, taking place March 28-30 in New Orleans, LA. Sessions in the Vascular Learning Pathway will highlight key developments in chronic limb-threatening ischemia, pulmonary embolism, peripheral arterial disease and renal denervation, along with landmark trial data, new therapies and discussions on carotid revascularization, hypertension device therapy, current controversies in the field and more.

Additionally, the PVD Learning Pathway will add special focus to science, advancements and the latest debates in pulmonary hypertension (PH). Foundational sessions, case-based learning and expert discussions will introduce you to the latest emerging technologies, including AI, wearables, and omics-driven insights that are redefining how PH is diagnosed and managed.

Can’t choose? Attend sessions from both! Register now to join forward-thinking sessions delivering cutting edge science and the latest advancements in care.

vascular system

Access ACC Resources For PAD Awareness Month

September 23, 2025

Announcements

As Peripheral Artery Disease (PAD) Awareness Month continues this September, access these resources for clinicians and patients alike to keep up to date on the latest in guidelines, clinical trials, management strategies and treatment options:

  • The 2024 PAD Guideline Hub presents the latest multisociety clinical practice guideline for lower extremity PAD, while an expert analysis article drills down into foot care as a critical component in managing the disease.
  • A JACC scientific statement provides a detailed scientific overview on antithrombotic strategies in PAD, and an expert analysis article highlights the six strategic goals of the PAD National Action Plan.
  • Episodes of ACC's CardiaCast Pulse Check podcast series introduce the basics of PAD and cover interventional treatment options.
  • See the latest on the STRIDE and SOUL trials on semaglutide for PAD outcomes, presented at ACC.25.
  • The CardioSmart PAD Hub empowers patients during their treatment with patient-facing resources, including symptom/treatment info, risk factors, lifestyle tips, clinician discussion guides and English/Spanish bilingual infographics.

View More Section News »

Resources